Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)
Autoimmune Disorder Multiple Sclerosis (MS) Primary Progressive Multiple Sclerosis (PPMS) Neurodegenerative Disorder Relapsing Multiple Sclerosis (RMS)
For the latest version of this information please go to www.forpatients.roche.com